DE60023008D1 - Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation - Google Patents
Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantationInfo
- Publication number
- DE60023008D1 DE60023008D1 DE60023008T DE60023008T DE60023008D1 DE 60023008 D1 DE60023008 D1 DE 60023008D1 DE 60023008 T DE60023008 T DE 60023008T DE 60023008 T DE60023008 T DE 60023008T DE 60023008 D1 DE60023008 D1 DE 60023008D1
- Authority
- DE
- Germany
- Prior art keywords
- organtransplantation
- prevent
- result
- chronic breathing
- breathing reaction
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000001684 chronic effect Effects 0.000 title abstract 2
- 230000029058 respiratory gaseous exchange Effects 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 abstract 2
- NZHGWWWHIYHZNX-UHFFFAOYSA-N 2-((3-(3,4-dimethoxyphenyl)-1-oxo-2-propenyl)amino)benzoic acid Chemical compound C1=C(OC)C(OC)=CC=C1C=CC(=O)NC1=CC=CC=C1C(O)=O NZHGWWWHIYHZNX-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
- 208000029078 coronary artery disease Diseases 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 230000008719 thickening Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
- 230000002792 vascular Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Vascular Medicine (AREA)
- Urology & Nephrology (AREA)
- Transplantation (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Orthopedics, Nursing, And Contraception (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP20327099 | 1999-07-16 | ||
| JP20327099 | 1999-07-16 | ||
| PCT/JP2000/004529 WO2001005394A1 (en) | 1999-07-16 | 2000-07-07 | Agents inhibiting chronic rejection reactions after organ transplantation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE60023008D1 true DE60023008D1 (de) | 2006-02-16 |
| DE60023008T2 DE60023008T2 (de) | 2006-07-06 |
Family
ID=16471275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE60023008T Expired - Fee Related DE60023008T2 (de) | 1999-07-16 | 2000-07-07 | Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US6552083B1 (de) |
| EP (1) | EP1197210B1 (de) |
| AT (1) | ATE305777T1 (de) |
| DE (1) | DE60023008T2 (de) |
| ES (1) | ES2250154T3 (de) |
| WO (1) | WO2001005394A1 (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002363075A (ja) * | 2001-06-05 | 2002-12-18 | Kao Corp | 高血圧症予防・治療剤 |
| US20050170019A1 (en) * | 2003-10-22 | 2005-08-04 | Fred Hutchinson Cancer Research Center | Methods, compositions and devices for inducing stasis in cells |
| CA2542806A1 (en) | 2003-10-22 | 2005-05-12 | Fred Hutchinson Cancer Research Center | Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms |
| US20050136125A1 (en) * | 2003-10-22 | 2005-06-23 | Roth Mark B. | Methods, compositions and devices for inducing stasis in cells, tissues, organs, and organisms |
| JP4966019B2 (ja) * | 2005-01-06 | 2012-07-04 | キッセイ薬品工業株式会社 | 慢性移植片対宿主症におけるドライアイの予防および治療剤 |
| CA2605631A1 (en) * | 2005-04-20 | 2006-10-26 | Fred Hutchinson Cancer Research Center | Methods, compositions and articles of manufacture for enhancing survivability of cells, tissues, organs, and organisms |
| US8470316B2 (en) | 2005-10-14 | 2013-06-25 | Chugai Seiyaku Kabushiki Kaisha | Agents for suppressing damage to transplanted islets after islet transplantation |
| CA2626688C (en) | 2005-10-21 | 2017-10-03 | Chugai Seiyaku Kabushiki Kaisha | Agents for treating cardiopathy |
| AR057582A1 (es) * | 2005-11-15 | 2007-12-05 | Nat Hospital Organization | Agentes para suprimir la induccion de linfocitos t citotoxicos |
| JPWO2007061029A1 (ja) * | 2005-11-25 | 2009-05-07 | 学校法人慶應義塾 | 前立腺癌治療剤 |
| CN101370521A (zh) * | 2006-01-27 | 2009-02-18 | 学校法人庆应义塾 | 伴有脉络膜血管生成的疾病的治疗药 |
| US9260516B2 (en) | 2006-04-07 | 2016-02-16 | Osaka University | Method for promoting muscle regeneration by administering an antibody to the IL-6 receptor |
| US20080089947A1 (en) * | 2006-08-18 | 2008-04-17 | Knox Clayton D | Calcium Influx Inhibitors in the Treatment of Ischemia |
| WO2008090901A1 (ja) * | 2007-01-23 | 2008-07-31 | Shinshu University | 慢性拒絶反応抑制剤 |
| CN104906581A (zh) * | 2008-06-05 | 2015-09-16 | 国立研究开发法人国立癌症研究中心 | 神经浸润抑制剂 |
| ES2474765T3 (es) | 2009-06-17 | 2014-07-09 | National University Corporation Kumamoto University | Agente profiláctico y/o terapéutico para la dismenorrea |
| US9539322B2 (en) | 2010-05-28 | 2017-01-10 | National University Corporation Hokkaido University | Method of enhancing an antitumor T cell response by administering an anti-IL-6 receptor antibody |
| CN102770132B (zh) * | 2010-12-08 | 2015-05-27 | 李先亮 | 苯甲酸衍生物的药物用途 |
| BR112017009440A2 (pt) * | 2014-11-06 | 2017-12-19 | Dana Farber Cancer Inst Inc | uso de composições que modulam a estrutura de cromatina quanto à doença do enxerto versus hospedeiro (gvhd) |
| US11851486B2 (en) | 2017-05-02 | 2023-12-26 | National Center Of Neurology And Psychiatry | Method for predicting and evaluating therapeutic effect in diseases related to IL-6 and neutrophils |
| EP3698808B1 (de) | 2017-10-20 | 2025-01-01 | Hyogo College Of Medicine | Anti-il-6 rezeptorantikörper enthaltende medizinische zusammensetzung zur verhinderung von postoperativer adhäsion |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2617407B2 (ja) | 1992-09-14 | 1997-06-04 | キッセイ薬品工業株式会社 | 血管内膜細胞過剰増殖疾患の予防および治療剤 |
-
2000
- 2000-07-07 US US10/030,915 patent/US6552083B1/en not_active Expired - Fee Related
- 2000-07-07 DE DE60023008T patent/DE60023008T2/de not_active Expired - Fee Related
- 2000-07-07 WO PCT/JP2000/004529 patent/WO2001005394A1/ja not_active Ceased
- 2000-07-07 EP EP00944318A patent/EP1197210B1/de not_active Expired - Lifetime
- 2000-07-07 ES ES00944318T patent/ES2250154T3/es not_active Expired - Lifetime
- 2000-07-07 AT AT00944318T patent/ATE305777T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1197210B1 (de) | 2005-10-05 |
| EP1197210A4 (de) | 2005-02-16 |
| US6552083B1 (en) | 2003-04-22 |
| ES2250154T3 (es) | 2006-04-16 |
| ATE305777T1 (de) | 2005-10-15 |
| WO2001005394A1 (en) | 2001-01-25 |
| EP1197210A1 (de) | 2002-04-17 |
| DE60023008T2 (de) | 2006-07-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60023008D1 (de) | Mittel zur verhinderung der chronischen abstossreaktion infolge einer organtransplantation | |
| DE60140491D1 (de) | Verwendung einer pharmazeutischen Zusammensetzung mit einem Para-Aminophenylessigsäurederivat für die Behandlung von entzündlichen Erkrankungen des Magen-Darmtrakts | |
| HRP20090281T1 (hr) | 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti | |
| ATE389395T1 (de) | Substituierte 2-aminotetraline zur vorbeugenden behandlung von morbus parkinson | |
| DK1309562T3 (da) | 4-Alkoxycyclohexan-1-aminocarboxylsyreestere og fremgangsmåde til fremstilling deraf | |
| HRP20060286T3 (en) | Tetrazole derivatives and methods of treatment of metabolic-related disorders thereof | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| ATE267191T1 (de) | Tricyclische aminderivate | |
| WO2000066094A3 (de) | Verwendung von verbindungen mit einem stickstoff-sauerstoff-heterocyclus als antiinfektiöse mittel | |
| DE60216239T8 (de) | Verwendung von Cyclohexenon-Derivaten zur Herstellung eines Arzneimittels zur Behandlung von Dysurie | |
| EP1393747A4 (de) | Mittel zur prävention/behandlung von alzheimer-krankheit | |
| ATE360423T1 (de) | Verwendung von chymase hemmern gegen vaskuläre lipidablagerung | |
| SI1970372T1 (sl) | Soli 9-oksoakridin-10-ocetne kisline z 1-alkilamino-1-deoksi-polioli | |
| EA200100586A1 (ru) | Применение производных фосфономуравьиной кислоты для лечения инфекций | |
| NO20033273L (no) | Anvendelse av (R)-ibuprofen-metansulfonamid og salter derav til behandlingog forhindring av avstötning av transplanterte organer | |
| NO20070421L (no) | Radiosensitiviserende middel | |
| ATE244258T1 (de) | Halo-derivate von 9-deoxo-9a-aza-9a- homerythromycin a | |
| EP1325918A4 (de) | Herzmuskelzellen-apoptose hemmstoffe und behandlung/vorbeugung von herzkrankheiten | |
| DE602005017629D1 (de) | Pharmazeutische zusammensetzungen zur behandlung von leishmaniasis | |
| ATE505193T1 (de) | Arzneimittelkombinationen zur behandlung von atemwegserkrankungen | |
| NO20013464L (no) | Anvendelse av 3-isoksazolidinoner og hydroksylaminsyrer for behandling av infeksjoner | |
| EA200100585A1 (ru) | Применение производных фосфономуравьиной кислоты для лечения инфекций | |
| NO993911D0 (no) | Remedier/Forebygningsmidler for åndedrettssykdommer | |
| DE602005022213D1 (de) | Verfahren zur herstellung von phenyl-2-pyrimidinyl-ketonen und neuen zwischenprodukten daraus | |
| GB0223234D0 (en) | Chemical compounds |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8339 | Ceased/non-payment of the annual fee |